{"id":"https://openalex.org/W2416979112","doi":"https://doi.org/10.1097/qad.0000000000000893","title":"The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy","display_name":"The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy","publication_year":2015,"publication_date":"2015-09-29","ids":{"openalex":"https://openalex.org/W2416979112","doi":"https://doi.org/10.1097/qad.0000000000000893","mag":"2416979112","pmid":"https://pubmed.ncbi.nlm.nih.gov/26418084","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4703444"},"language":"en","primary_location":{"id":"doi:10.1097/qad.0000000000000893","doi":"https://doi.org/10.1097/qad.0000000000000893","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0000000000000893","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4703444","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090564785","display_name":"John Robert Koethe","orcid":"https://orcid.org/0000-0001-6490-6942","observed_orcids":["https://orcid.org/0000-0001-6490-6942"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John R. Koethe","raw_affiliation_strings":["aDivision of Infectious DiseasesbDepartment of MedicinecDepartment of BiostatisticsdDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","Division of Infectious Diseases","e-mail: [email\u00a0protected]","fax: +1 615 343-6160","to John R. Koethe, MD, Division of Infectious Diseases, Vanderbilt University Medical Center, A2200-MCN, 1161 21st Avenue South, Nashville, TN 37232-2582, USA. Tel: +1 615 322 2035"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aDivision of Infectious DiseasesbDepartment of MedicinecDepartment of BiostatisticsdDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Division of Infectious Diseases","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 615 343-6160","institution_ids":[]},{"raw_affiliation_string":"to John R. Koethe, MD, Division of Infectious Diseases, Vanderbilt University Medical Center, A2200-MCN, 1161 21st Avenue South, Nashville, TN 37232-2582, USA. Tel: +1 615 322 2035","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083105013","display_name":"Heather N. Grome","orcid":"https://orcid.org/0000-0002-7967-8986","observed_orcids":["https://orcid.org/0000-0002-7967-8986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather Grome","raw_affiliation_strings":["Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003593760","display_name":"Cathy A. Jenkins","orcid":"https://orcid.org/0000-0001-7217-2985","observed_orcids":["https://orcid.org/0000-0001-7217-2985"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cathy A. Jenkins","raw_affiliation_strings":["Department of Biostatistics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067647063","display_name":"Spyros A. Kalams","orcid":"https://orcid.org/0000-0003-0098-7995","observed_orcids":["https://orcid.org/0000-0003-0098-7995"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spyros A. Kalams","raw_affiliation_strings":["Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","Division of Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Division of Infectious Diseases","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076748422","display_name":"Timothy R. Sterling","orcid":"https://orcid.org/0000-0002-4822-6979","observed_orcids":["https://orcid.org/0000-0002-4822-6979"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy R. Sterling","raw_affiliation_strings":["Division of Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5090564785"],"corresponding_institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"],"apc_list":null,"apc_paid":null,"fwci":5.4885,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.9653723,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"30","issue":"1","first_page":"83","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.890999972820282},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9190000295639038},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.8600000143051147},{"id":"https://openalex.org/keywords/tenofovir","display_name":"tenofovir","score":0.9390000104904175},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.7910000085830688},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7910000085830688},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.5640000104904175},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.6710000038146973},{"id":"https://openalex.org/keywords/endothelial-activation","display_name":"endothelial activation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7250000238418579},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9760000109672546},{"id":"https://openalex.org/keywords/soluble-cell-adhesion-molecules","display_name":"soluble adhesion molecules","score":0.75},{"id":"https://openalex.org/keywords/carotid-intima-media-thickness","display_name":"carotid intima-media thickness","score":0.9399999976158142},{"id":"https://openalex.org/keywords/flow-mediated-dilation","display_name":"flow-mediated dilation","score":0.8840000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7262009382247925},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6693300008773804},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5360890030860901},{"id":"https://openalex.org/C2777604165","wikidata":"https://www.wikidata.org/wiki/Q503643","display_name":"Brachial artery","level":3,"score":0.5300730466842651},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.49613580107688904},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.4916761517524719},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.415374219417572},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.4151766896247864},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.40407589077949524},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.394611656665802},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.3834284543991089},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.16722211241722107},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.1194697916507721},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.11641490459442139}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/qad.0000000000000893","doi":"https://doi.org/10.1097/qad.0000000000000893","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0000000000000893","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:26418084","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26418084","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Comparative Study"},{"id":"pmh:oai:europepmc.org:4101840","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4703444","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4703444","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4703444","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"AIDS","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4101840","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4703444","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G4555345758","display_name":null,"funder_award_id":"K23100700","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G5265894092","display_name":"The Role of Obesity and Adipocytes in Immune Activation on Antiretroviral Therapy","funder_award_id":"K23AI100700","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6413661403","display_name":"Mentoring in HIV and Tuberculosis Research","funder_award_id":"K24AI065298","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6628171993","display_name":"The Vanderbilt Institute for Clinical and Translational Research (VICTR) UL1","funder_award_id":"UL1RR024975","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G7773456091","display_name":"The Vanderbilt Institute for Clinical and Translational Research (VICTR)","funder_award_id":"UL1TR000445","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000076998","display_name":"Tennessee Center for AIDS Research (TN-CFAR)","funder_award_id":"P30AI110527","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W56851055","https://openalex.org/W1426208733","https://openalex.org/W1767400858","https://openalex.org/W1910950825","https://openalex.org/W1951521958","https://openalex.org/W1969412791","https://openalex.org/W1976405336","https://openalex.org/W1986484921","https://openalex.org/W1988062692","https://openalex.org/W1992160694","https://openalex.org/W1993959456","https://openalex.org/W1996967878","https://openalex.org/W1999494637","https://openalex.org/W2017131494","https://openalex.org/W2019499610","https://openalex.org/W2024420050","https://openalex.org/W2047040270","https://openalex.org/W2047542844","https://openalex.org/W2050107837","https://openalex.org/W2053577233","https://openalex.org/W2058294329","https://openalex.org/W2065111736","https://openalex.org/W2065148379","https://openalex.org/W2066898102","https://openalex.org/W2073738273","https://openalex.org/W2089387580","https://openalex.org/W2098152094","https://openalex.org/W2110717475","https://openalex.org/W2123354892","https://openalex.org/W2127277443","https://openalex.org/W2129785124","https://openalex.org/W2141449346","https://openalex.org/W2142647642","https://openalex.org/W2146974699","https://openalex.org/W2147210767","https://openalex.org/W2149812642","https://openalex.org/W2150144835","https://openalex.org/W2152306555","https://openalex.org/W2153136696","https://openalex.org/W2161313492","https://openalex.org/W2162249283","https://openalex.org/W2166168319","https://openalex.org/W2167607159","https://openalex.org/W2169319632","https://openalex.org/W2190014693","https://openalex.org/W2313892069","https://openalex.org/W2465490209","https://openalex.org/W2971416110","https://openalex.org/W6602297089"],"related_works":["https://openalex.org/W1969412791","https://openalex.org/W2465490209","https://openalex.org/W2501063285","https://openalex.org/W4211196290","https://openalex.org/W2893912923","https://openalex.org/W2317012991","https://openalex.org/W2754070234","https://openalex.org/W7126862853","https://openalex.org/W1986484921","https://openalex.org/W4386228754"],"abstract_inverted_index":{"OBJECTIVE:":[0],"This":[1],"study":[2,29],"assessed":[3],"the":[4],"effect":[5],"of":[6],"obesity":[7,159],"on":[8,18,41,270,279],"metabolic":[9],"and":[10,36,44,59,87,90,96,100,104,111,121,125,146,169,176,196,202,206,219,231,242,250,258,272],"cardiovascular":[11,71],"disease":[12],"risk":[13],"factors":[14],"in":[15,275],"HIV-infected":[16,39,98,103,127,144,157,213,277],"adults":[17,278],"antiretroviral":[19,281],"therapy":[20],"with":[21,30,46,162,234],"sustained":[22],"virologic":[23],"suppression.":[24],"DESIGN:":[25],"Observational,":[26],"comparative":[27],"cohort":[28,117],"three":[31],"group-matched":[32],"arms:":[33],"35":[34,37],"nonobese":[35,95],"obese":[38,61,97,102,126,143,235],"persons":[40],"efavirenz,":[42],"tenofovir":[43],"emtricitabine":[45],"plasma":[47],"HIV-1":[48],"RNA":[49],"less":[50,147],"than":[51,56,142],"50":[52],"copies/ml":[53],"for":[54,154,240],"more":[55],"2":[57],"years,":[58],"30":[60],"HIV-uninfected":[62,105,138,236],"controls.":[63],"Patients":[64],"did":[65,129],"not":[66,130],"have":[67],"diabetes":[68],"or":[69,134],"known":[70],"disease.":[72],"METHODS:":[73],"We":[74],"compared":[75,233],"glucose":[76,248],"tolerance,":[77],"serum":[78,171],"lipids,":[79],"brachial":[80],"artery":[81],"flow-mediated":[82],"dilation,":[83],"carotid":[84,203],"intima-media":[85,204],"thickness,":[86],"soluble":[88],"inflammatory":[89],"vascular":[91,197,226],"adhesion":[92,193,199,223,228],"markers":[93],"between":[94,101],"patients,":[99,106,158],"using":[107],"Wilcoxon":[108],"rank-sum":[109],"tests":[110],"multivariate":[112],"linear":[113],"regression.":[114],"RESULTS:":[115],"The":[116],"was":[118,160],"52%":[119],"men":[120],"48%":[122],"nonwhite.":[123],"Nonobese":[124],"patients":[128,145,214],"differ":[131],"by":[132],"clinical":[133],"demographic":[135],"characteristics.":[136],"Obese":[137,212,276],"controls":[139,237],"were":[140],"younger":[141],"likely":[148],"to":[149,252],"smoke":[150],"(P":[151,183],"<":[152,184],"0.03":[153],"both).":[155],"Among":[156],"associated":[161],"greater":[163,220],"insulin":[164,167],"release,":[165],"lower":[166],"sensitivity,":[168],"higher":[170],"high-sensitivity":[172,254],"C-reactive":[173,255],"protein,":[174,256],"interleukin-6,":[175,257],"tumor":[177,259],"necrosis":[178,260],"factor-\u03b1":[179,261],"receptor":[180,262],"1":[181,195,230,263],"levels":[182],"0.001),":[185],"but":[186,265],"similar":[187],"lipid":[188,217],"profiles,":[189],"sCD14,":[190,232],"sCD163,":[191],"intercellular":[192,222],"molecule":[194,200,224,229],"cell":[198,227],"1,":[201,225],"thickness":[205],"flow":[207],"mediated":[208],"dilation.":[209],"In":[210],"contrast,":[211],"had":[215],"adverse":[216],"changes,":[218],"circulating":[221,253],"after":[238],"adjusting":[239],"age":[241],"other":[243],"factors.":[244],"CONCLUSION:":[245],"Obesity":[246],"impairs":[247],"metabolism":[249],"contributes":[251],"levels,":[264],"has":[266],"few":[267],"additive":[268],"effects":[269],"dyslipidemia":[271],"endothelial":[273],"activation,":[274],"long-term":[280],"therapy.":[282]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}